Welcome to iChemical.com!

In the below part, please select the country you want us to ship to: Please note that once you've selected a shipping country, all pricing information on our website will be automatically updated to include door-to-door shipping to the country you specified.

    OK
    Get Quote Login
    368-16-1

    Catalog No. EBD89586

    CAS 368-16-1

    Name (2S)-2-amino-3-(3-methylimidazol-4-yl)propanoic acid

    Get Quote
    Basic Information

    Synonyms: 3-methyl-L-histidine H-His(3-Me)-OH 3-methylhistidine 3-Methyl-L-HistidineN-Hydrate (2S)-2-amino-3-(3-methylimidazol-4-yl)propanoicacid

    Molecular Formula: C7H11N3O2

    Molecular Weight: 169.18

    Categories: Medicinal Chemistry > Biochemicals and Life Science Reagents > Amino Acids and Derivatives Medicinal Chemistry > Pharmaceutical Intermediates > Heterocyclic Intermediates

    Product Description:
    3-Methyl-L-histidine is a naturally occurring, post-translationally modified amino acid derivative. It is formed by the methylation of histidine residues in proteins, most notably in actin and myosin. This modification is irreversible and serves as a specific biomarker for muscle protein breakdown. Its primary significance lies in biomedical research and clinical diagnostics. 3-Methyl-L-histidine is widely used as a biochemical marker to assess skeletal muscle catabolism and protein turnover rates in various physiological and pathological conditions, such as trauma, sepsis, and muscular dystrophy. It is also employed in studies related to muscle metabolism and aging. As a modified amino acid, it finds application as a specialized building block in peptide synthesis and as a reference standard in analytical chemistry, particularly in liquid chromatography-mass spectrometry (LC-MS) methods for quantifying muscle-derived metabolites in biological fluids like urine and plasma.
    Physical Properties

    Boiling Point: 415 °C at 760 mmHg

    Flash Point: 204.8 °C

    Density: 1.37 g/cm3

    Storage: Store at RT.

    mg g kg ml l t